BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 12647082)

  • 21. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of superior mesenteric and portal vein thrombosis with direct thrombolytic infusion via an operatively placed mesenteric catheter.
    Kaplan JL; Weintraub SL; Hunt JP; Gonzalez A; Lopera J; Brazzini A
    Am Surg; 2004 Jul; 70(7):600-4. PubMed ID: 15279182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A retrospective study on the use of a low-molecular-weight heparin for thromboembolism prophylaxis in large-volume liposuction and body contouring procedures.
    Newall G; Ruiz-Razura A; Mentz HA; Patronella CK; Ibarra FR; Zarak A
    Aesthetic Plast Surg; 2006; 30(1):86-95; discussion 96-7. PubMed ID: 16404651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Low molecular weight heparin: the first 5 years].
    Mannucci PM
    Ann Ital Med Int; 1997; 12(2):61-2. PubMed ID: 9333314
    [No Abstract]   [Full Text] [Related]  

  • 25. Cardiology patient pages. Prevention of deep vein thrombosis and pulmonary embolism.
    Goldhaber SZ; Fanikos J
    Circulation; 2004 Oct; 110(16):e445-7. PubMed ID: 15492324
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
    Harenberg J; Riess H; Büller HR; Brom J; Weidinger G; Huisman MV
    Haematologica; 2003 Oct; 88(10):1157-62. PubMed ID: 14555312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Acute pre-hepatic portal thrombosis: diagnosis and therapy].
    Di Carlo I; Lombardo R; Di Raimondo F; Petrillo G; Puleo S
    Minerva Chir; 1997; 52(7-8):955-8. PubMed ID: 9411299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low molecular weight heparin in management and prevention of portal vein thrombosis.
    Lisman T
    Thromb Res; 2014 Oct; 134(4):761-2. PubMed ID: 25179517
    [No Abstract]   [Full Text] [Related]  

  • 29. Acute portal vein thrombosis secondary to donor/recipient portal vein diameter mismatch after orthotopic liver transplantation: a case report.
    Doria C; Marino IR
    Int Surg; 2003; 88(4):184-7. PubMed ID: 14717522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Portal vein thrombosis as a complication of laparoscopic sleeve gastrectomy.
    Lopez R; Flint R
    N Z Med J; 2013 Nov; 126(1386):103-5. PubMed ID: 24316998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Portal vein thrombosis associated with hepatic encephalopathy].
    Iwatani N; Inatomi Y; Yonehara T; Fujioka S; Hashimoto Y; Hirano T; Uchino M
    Rinsho Shinkeigaku; 2005 Mar; 45(3):235-8. PubMed ID: 15835295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-molecular-weight heparin or oral anticoagulation for secondary prevention of deep vein thrombosis in cancer patients.
    Levine M
    Semin Thromb Hemost; 2003 Dec; 29 Suppl 1():9-11. PubMed ID: 14730472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome of portal injuries following bariatric operations.
    Huerta S; Li Z; Livingston EH
    Obes Surg; 2006 Jan; 16(1):105-9. PubMed ID: 16417768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Portal venous thrombosis as a complication, following appendicitis].
    Paajanen H; Miettinen P; Farin P; Alhava E
    Duodecim; 1996; 112(11):999-1001. PubMed ID: 10592994
    [No Abstract]   [Full Text] [Related]  

  • 35. Melagatran and ximelagatran: new drug. No real simplification of anticoagulant therapy.
    Prescrire Int; 2005 Aug; 14(78):127-32. PubMed ID: 16106594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute portal vein thrombosis after splenic embolization and splenectomy for autoimmune pancytopenia.
    Nounla J; Sorge I; Deckert F; Lenk H; Tröbs RB
    Eur J Pediatr Surg; 2005 Oct; 15(5):358-60. PubMed ID: 16254850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple-vein thrombosis and pulmonary embolism after pacemaker implantation treated by thrombolysis.
    Khalameizer V; Polishchuk I; Pancheva N; Jafari J; Scharf S; Reisin L; Ovsyshcher IE
    Europace; 2004 Sep; 6(5):453-6. PubMed ID: 15294272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Portal vein thrombosis in a patient with breast carcinoma.
    Nolte JE; Paz Z
    Isr Med Assoc J; 2009 May; 11(5):315-6. PubMed ID: 19637514
    [No Abstract]   [Full Text] [Related]  

  • 39. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes].
    MMW Fortschr Med; 2003 Jun; 145(24):56. PubMed ID: 12866309
    [No Abstract]   [Full Text] [Related]  

  • 40. Prospective study of the incidence and risk factors of postsplenectomy thrombosis of the portal, mesenteric, and splenic veins.
    Stamou KM; Toutouzas KG; Kekis PB; Nakos S; Gafou A; Manouras A; Krespis E; Katsaragakis S; Bramis J
    Arch Surg; 2006 Jul; 141(7):663-9. PubMed ID: 16847237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.